A new study based on German long-COVID patients shows 68% experience the same symptoms in year 2 as in year 1 of the chronic ...
The vaccine, typically given as 3 doses, was developed by China and hadn't previously been used in outbreak settings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback